Please be aware that this event has been cancelled.

Why Partner?

Why Partner with the Multi-Omics Based Drug Discovery & Development Summit?

Multi-omics is fast being adopted by leading industry players to generate unique, in-depth insights into pathology and disease evolution, as well as to accelerate target and biomarker discovery and inform patient selection and clinical development.

Despite advancements in multi-omics technologies, omics analysis, tissue sourcing and processing, sequencing, and data storage remain a challenge.

The Multi-Omics Based Drug Discovery & Development Summit provides a unique platform to connect with experts in pathology, translation, computational biology and biomarker discovery to showcase your solutions and services.

Official Brochure

Experts are Looking for Innovative Solutions in…

Omics Data Analysis

Secure, Efficient Data Storage

AI & ML to Support Data Analysis

Data Visualisation & Sharing

Sequencing Technologies

Tissue Sourcing & Processing

...Do You Have What They're Looking For?

Our Partnership Opportunities

Presentations for Multi-Omics Experts

Presentations
Share your data on accurately analysing large-scale genomic, epigenomic, transcriptomic, proteomic and metabolomic data

Demonstrate your omics technology

Exhibit
Demonstrate your omics technology and showcase your customer service skills to create a lasting impression

Multi Omics Audience

Full Delegate List
Plan your discussions in advance with exclusive access to the names of all the biopharma experts in the room

Multi Omics Visibility

Branding
On-site and online branding ahead of and following the meeting to boost your visibility amongst the multi-omics community

Connect with the Multi-Omics Industry

Sponsored Drinks Reception
Socialise with your next industry partners, create meaningful connections and converse directly with the market

Network With Multi-Omics Experts

Networking
Dedicated business card swaps, speed networking and a poster session will allow you to grow your network

Multi-Omics News Hub
Omics, Genomics, Proteomics, & Biomarker Industry News from Illumina, Nvida